These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23628401)

  • 1. Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration.
    Rossi A; Buttini F; Colombo P; Mor M; Pala D; Bortolotti F; Colombo G
    Int J Pharm; 2013 Jul; 451(1-2):50-6. PubMed ID: 23628401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition specification of teicoplanin based on its estimated relative bioavailability.
    Boix-Montañes A; Garcia-Arieta A
    Drug Dev Ind Pharm; 2015 Feb; 41(2):218-23. PubMed ID: 24506456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. About the equivalence between different batches of a glycopeptide drug.
    Boix-Montañes A; Garcia-Arieta A
    Pharm Dev Technol; 2016 Aug; 21(5):642-5. PubMed ID: 25886080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-centre retrospective observational study comparing trough blood concentration and safety of teicoplanin formulations.
    Shinoda R; Shinoda Y; Ohashi K; Matsuoka T; Hirose T; Sugiyama T; Yoshimura T
    J Infect Chemother; 2019 Jul; 25(7):563-566. PubMed ID: 30929977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinoplanes teichomyceticus ATCC 31121 as a cell factory for producing teicoplanin.
    Taurino C; Frattini L; Marcone GL; Gastaldo L; Marinelli F
    Microb Cell Fact; 2011 Oct; 10():82. PubMed ID: 22008254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicomponent antibiotic substances produced by fermentation: implications for regulatory authorities, critically ill patients and generics.
    Brink AJ; Richards GA; Colombo G; Bortolotti F; Colombo P; Jehl F
    Int J Antimicrob Agents; 2014 Jan; 43(1):1-6. PubMed ID: 23920094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycerol affects the acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus MSl2210.
    Park HR; Lee JC; Hwang JH; Park DJ; Kim CJ
    Microbiol Res; 2009; 164(5):588-92. PubMed ID: 17659865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comments on generic antibiotics].
    Levêque D; Gourieux B
    Med Mal Infect; 2013 Jan; 43(1):35-6. PubMed ID: 23287656
    [No Abstract]   [Full Text] [Related]  

  • 10. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis, biotechnological production, and application of teicoplanin: current state and perspectives.
    Jung HM; Jeya M; Kim SY; Moon HJ; Kumar Singh R; Zhang YW; Lee JK
    Appl Microbiol Biotechnol; 2009 Sep; 84(3):417-28. PubMed ID: 19609520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring quality and its potential effects of multi-components antibiotic: consistency evaluation between matrix components ratio and microbiological potency of teicoplanin.
    Chang Y; Wang N; Yao SC; Hu CQ
    J Antibiot (Tokyo); 2013 Nov; 66(11):641-6. PubMed ID: 23820615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structure determination of a novel complex of the teicoplanin family.
    Quarta C; Borghi A; Zerilli LF; De Pietro MT; Ferrari P; Trani A; Lancini GC
    J Antibiot (Tokyo); 1996 Jul; 49(7):644-50. PubMed ID: 8784424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-inpatient use of teicoplanin.
    Nathwani D
    Int J Clin Pract; 1998; 52(8):577-81. PubMed ID: 10622058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic antibiotic drugs: is effectiveness guaranteed?
    Gauzit R; Lakdhari M
    Med Mal Infect; 2012 Apr; 42(4):141-8. PubMed ID: 22480963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin: characterization of two glycosyltransferases and the key acyltransferase.
    Li TL; Huang F; Haydock SF; Mironenko T; Leadlay PF; Spencer JB
    Chem Biol; 2004 Jan; 11(1):107-19. PubMed ID: 15113000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
    Meredith PA
    Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teicoplanin: an investigational glycopeptide antibiotic.
    Pryka RD; Rodvold KA; Rotschafer JC
    Clin Pharm; 1988 Sep; 7(9):647-58. PubMed ID: 2977108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of teicoplanin by valine analogue-resistant mutant strains of Actinoplanes teichomyceticus.
    Jin ZH; Wang MR; Cen PL
    Appl Microbiol Biotechnol; 2002 Jan; 58(1):63-6. PubMed ID: 11833531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and haemostatic effects of generic versions of enoxaparin available for clinical use in Brazil: similarity to the original drug.
    Glauser BF; Vairo BC; Oliveira SN; Cinelli LP; Pereira MS; Mourão PA
    Thromb Haemost; 2012 Feb; 107(2):302-14. PubMed ID: 22234635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.